Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases

Eli Stahl, Giulia Roda, Amanda Dobbyn, Jianzhong Hu, Zhongyang Zhang, Helga Westerlind, Ferdinando Bonfiglio, Towfique Raj, Joana Torres, Anli Chen, Robert Petras, Darrell S. Pardi, Alina C. Iuga, Gabriel S. Levi, Wenqing Cao, Prantesh Jain, Florian Rieder, Ilyssa O. Gordon, Judy H. Cho, Mauro D'AmatoNoam Harpaz, Ke Hao, Jean Frederic Colombel, Inga Peter

Research output: Contribution to journalArticle

Abstract

Background & Aims: Collagenous colitis (CC) is an inflammatory bowel disorder with unknown etiopathogenesis involving HLA-related immune-mediated responses and environmental and genetic risk factors. We carried out an array-based genetic association study in a cohort of patients with CC and investigated the common genetic basis between CC and Crohn's disease (CD), ulcerative colitis (UC), and celiac disease. Methods: DNA from 804 CC formalin-fixed, paraffin-embedded tissue samples was genotyped with Illumina Immunochip. Matching genotype data on control samples and CD, UC, and celiac disease cases were provided by the respective consortia. A discovery association study followed by meta-analysis with an independent cohort, polygenic risk score calculation, and cross-phenotype analyses were performed. Enrichment of regulatory expression quantitative trait loci among the CC variants was assessed in hemopoietic and intestinal cells. Results: Three HLA alleles (HLA-B∗08:01, HLA-DRB1∗03:01, and HLA-DQB1∗02:01), related to the ancestral haplotype 8.1, were significantly associated with increased CC risk. We also identified an independent protective effect of HLA-DRB1∗04:01 on CC risk. Polygenic risk score quantifying the risk across multiple susceptibility loci was strongly associated with CC risk. An enrichment of expression quantitative trait loci was detected among the CC-susceptibility variants in various cell types. The cross-phenotype analysis identified a complex pattern of polygenic pleiotropy between CC and other immune-mediated diseases. Conclusions: In this largest genetic study of CC to date with histologically confirmed diagnosis, we strongly implicated the HLA locus and proposed potential non-HLA mechanisms in disease pathogenesis. We also detected a shared genetic risk between CC, celiac disease, CD, and UC, which supports clinical observations of comorbidity.

Original languageEnglish (US)
Pages (from-to)549-561.e8
JournalGastroenterology
Volume159
Issue number2
DOIs
StatePublished - Aug 2020

Keywords

  • Collagenous Colitis
  • Crohn's Disease
  • HLA
  • Immunochip

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases'. Together they form a unique fingerprint.

  • Cite this

    Stahl, E., Roda, G., Dobbyn, A., Hu, J., Zhang, Z., Westerlind, H., Bonfiglio, F., Raj, T., Torres, J., Chen, A., Petras, R., Pardi, D. S., Iuga, A. C., Levi, G. S., Cao, W., Jain, P., Rieder, F., Gordon, I. O., Cho, J. H., ... Peter, I. (2020). Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases. Gastroenterology, 159(2), 549-561.e8. https://doi.org/10.1053/j.gastro.2020.04.063